OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection de…
$3.44+2.08%
报价 2026-11-06
市值
$237.3M
EV
$159.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -23.6%
$2.11$4.50
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| OSUROraSure Technologies, Inc. | $237.3M | +2.1% | +4.4% | 41% | – | – | – | |
| NAUTNautilus Biotechnology, Inc. | $284M | +3.7% | -61.1% | -362.5% | – | – | – | |
| PREPrenetics Global Limited | $270M | -1.1% | – | 62.6% | – | – | – | |
| PROFProfound Medical Corp. | $263.4M | +4.8% | – | 71.7% | – | – | – | |
| UTMDUtah Medical Products, Inc. | $229.2M | +1.7% | – | 52.9% | 19.1x | 7.4x | 21.6x | |
| STIMNeuronetics, Inc. | $163.8M | -11.5% | +8.8% | 50.7% | – | – | – | |
| TARAProtara Therapeutics, Inc. | $135.9M | +8.0% | -10.4% | 0% | – | – | – | |
| NTHINeonc Technologies Holdings, Inc. | $100.5M | +9.1% | -100.0% | 0% | – | – | – | |
| CATXPerspective Therapeutics, Inc. | $95.9M | +6.5% | -54.5% | -419.4% | – | – | – | |
| 同行中位数 | – | – | -54.5% | 25.3% | 19.1x | 7.4x | 21.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。